Responses

This article has a correction. Please see:

PDF
Extended report
Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]
Publication Date - String

Vertical Tabs

Other responses

  • Published on:
    Response to Gonzalez-Gay's eLetter on Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review
    • Michael T Nurmohamed, MD
    • Other Contributors:
      • Anna Jamnitski, Deborah Symmons, Mike Peters, Naveed Sattar, Iain McInnes

    Dear Editor,

    In their comments about our systematic review on cardiovascular (CV) comorbidities in patients with psoriatic arthritis, (1) dr Gonzalez-Gay and colleagues, point out that in their studies, (2,3) in contrast to our Table 4, they did demonstrate a correlation between inflammatory parameters and flow-mediated dilatation (FMD) or intima media thickness (IMT). This is indeed correct when these tests are c...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis. Comment on the article by Jamnistki et al.

    Dear Editor,

    We read with great interest the elegant systematic review on cardiovascular (CV) comorbidities in patients with psoriatic arthritis (PsA) published in the February 2013 issue of ARD by Jamnitski et al.[1] Overall, we agree that there is an increased CV risk in patients with PsA similar to that observed in patients with rheumatoid arthritis (RA).[2] Therefore, adequate CV risk stratification is also re...

    Show More
    Conflict of Interest:
    None declared.